Volume 106, Issue 3 pp. 1268-1279
Original Research Report

Reduced cell attachment to poly(2-hydroxyethyl methacrylate)-coated ventricular catheters in vitro

Brian W. Hanak

Corresponding Author

Brian W. Hanak

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington

Department of Neurological Surgery, University of Washington, Seattle, Washington

Brian W. Hanak and Chia-Yun Hsieh are co-first authors.

Correspondence to: Brian W. Hanak, e-mail: [email protected]Search for more papers by this author
Chia-Yun Hsieh

Chia-Yun Hsieh

Department of Chemical and Biological Engineering, Drexel University, Philadelphia, Pennsylvania

Brian W. Hanak and Chia-Yun Hsieh are co-first authors.

Search for more papers by this author
William Donaldson

William Donaldson

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington

Search for more papers by this author
Samuel R. Browd

Samuel R. Browd

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington

Department of Neurological Surgery, University of Washington, Seattle, Washington

Search for more papers by this author
Kenneth K. S. Lau

Kenneth K. S. Lau

Department of Chemical and Biological Engineering, Drexel University, Philadelphia, Pennsylvania

Search for more papers by this author
William Shain

William Shain

Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington

Search for more papers by this author
First published: 20 June 2017
Citations: 36

Abstract

The majority of patients with hydrocephalus are dependent on ventriculoperitoneal shunts for diversion of excess cerebrospinal fluid. Unfortunately, these shunts are failure-prone and over half of all life-threatening pediatric failures are caused by obstruction of the ventricular catheter by the brain's resident immune cells, reactive microglia and astrocytes. Poly(2-hydroxyethyl methacrylate) (PHEMA) hydrogels are widely used for biomedical implants. The extreme hydrophilicity of PHEMA confers resistance to protein fouling, making it a strong candidate coating for ventricular catheters. With the advent of initiated chemical vapor deposition (iCVD), a solvent-free coating technology that creates a polymer in thin film form on a substrate surface by introducing gaseous reactant species into a vacuum reactor, it is now possible to apply uniform polymer coatings on complex three-dimensional substrate surfaces. iCVD was utilized to coat commercially available ventricular catheters with PHEMA. The chemical structure was confirmed on catheter surfaces using Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy. PHEMA coating morphology was characterized by scanning electron microscopy. Testing PHEMA-coated catheters against uncoated clinical-grade catheters in an in vitro hydrocephalus catheter bioreactor containing co-cultured astrocytes and microglia revealed significant reductions in cell attachment to PHEMA-coated catheters at both 17-day and 6-week time points. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1268–1279, 2018.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.